Omada Health Inc
OMDA17.260USD
-0.120-0.69%
Market hours （ET）Quotes delayed by 15 min
962.15MMarket Cap
LossP/E TTM
More Details of Omada Health Inc Company
Omada Health Inc. is a virtual-first healthcare provider that nurtures lifelong health. The Company has one operating segment, namely all virtual care program product offerings. The Company’s member-facing platform is designed to offer an integrated experience that encompasses the full range of direct interactions. It offers range of programs like Omada for Prevention & Weight Health, Omada for Diabetes, Omada for Hypertension, Omada for musculoskeletal (MSK), and Omada GLP-1 Care Tracks. Its Omada for Prevention & Weight Health programs focus on prediabetes and weight management, two critical elements of preventing diabetes and heart disease. Its Omada for Diabetes program is designed to help members with type 1 or type 2 diabetes achieve stable blood glucose levels and meet and reach their goals for reducing hemoglobin A1C. Its Omada for Hypertension is designed to help reduce members blood pressure and help them maintain healthy blood pressure.
Company Info
Ticker SymbolOMDA
Company nameOmada Health Inc
IPO dateJun 06, 2025
CEOMr. Sean Duffy
Number of employees849
Security typeOrdinary Share
Fiscal year-endJun 06
Address500 Sansome Street
CitySAN FRANCISCO
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code94111
Phone18889878337
Websitehttps://www.omadahealth.com/
Ticker SymbolOMDA
IPO dateJun 06, 2025
CEOMr. Sean Duffy
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Wei-Li Shao
Mr. Wei-Li Shao
President
President
579.10K
--
Mr. Trevor Fetter
Mr. Trevor Fetter
Independent Director
Independent Director
231.94K
+0.11%
Ms. Jeryl Hilleman
Ms. Jeryl Hilleman
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
209.26K
+0.18%
Mr. Adam Stavisky
Mr. Adam Stavisky
Independent Director
Independent Director
22.92K
--
Ms. Julie D. Klapstein
Ms. Julie D. Klapstein
Independent Director
Independent Director
22.92K
--
Dr. Anne Beal, M.D.
Dr. Anne Beal, M.D.
Independent Director
Independent Director
16.67K
--
Dr. Jonathan D. (Jon) Root, M.D.
Dr. Jonathan D. (Jon) Root, M.D.
Independent Director
Independent Director
237.00
--
Dr. Sachin H. Jain, M.D.
Dr. Sachin H. Jain, M.D.
Independent Director
Independent Director
--
--
Mr. Steve Cook
Mr. Steve Cook
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Sean Duffy
Mr. Sean Duffy
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Wei-Li Shao
Mr. Wei-Li Shao
President
President
579.10K
--
Mr. Trevor Fetter
Mr. Trevor Fetter
Independent Director
Independent Director
231.94K
+0.11%
Ms. Jeryl Hilleman
Ms. Jeryl Hilleman
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
209.26K
+0.18%
Mr. Adam Stavisky
Mr. Adam Stavisky
Independent Director
Independent Director
22.92K
--
Ms. Julie D. Klapstein
Ms. Julie D. Klapstein
Independent Director
Independent Director
22.92K
--
Dr. Anne Beal, M.D.
Dr. Anne Beal, M.D.
Independent Director
Independent Director
16.67K
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: 13 hours ago
Updated: 13 hours ago
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
9.84%
Revelation Partners, LLC
9.15%
U.S. Venture Partners
8.29%
Andreessen Horowitz
8.11%
Cigna Ventures LLC
6.05%
Other
58.57%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
9.84%
Revelation Partners, LLC
9.15%
U.S. Venture Partners
8.29%
Andreessen Horowitz
8.11%
Cigna Ventures LLC
6.05%
Other
58.57%
Shareholder Types
Shareholders
Proportion
Venture Capital
25.59%
Investment Advisor
19.10%
Corporation
6.97%
Individual Investor
6.09%
Investment Advisor/Hedge Fund
1.10%
Other
41.15%
Institutional Shareholding
Updated: Wed, Jul 2
Updated: Wed, Jul 2
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
16
31.13M
54.69%
+31.13M
2025Q2
19
32.89M
57.78%
+32.89M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
4.45M
7.81%
+4.45M
--
Jun 06, 2025
Revelation Partners, LLC
5.21M
9.15%
+5.21M
--
Jun 06, 2025
U.S. Venture Partners
4.72M
8.29%
+4.72M
--
Jun 06, 2025
Andreessen Horowitz
4.61M
8.11%
+4.61M
--
Jun 06, 2025
Cigna Ventures LLC
3.44M
6.05%
+3.44M
--
Jun 06, 2025
aMoon Fund
2.70M
4.75%
+2.70M
--
Jun 06, 2025
Norwest Venture Partners
2.53M
4.45%
+2.53M
--
Jun 06, 2025
Duffy (Sean P M.D.)
2.01M
3.54%
+2.01M
--
Jun 06, 2025
Shao (Wei-Li)
579.10K
1.02%
+579.10K
--
Jun 06, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
